SOLVETX

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 8 Nov 2022

Owner Info

Solve Therapeutics, Inc.

11045 Roselle St., Suite 130

San Diego CA 92121, UNITED STATES OF AMERICA

Serial Number

2294450 filed on 22 Jul 2022

Correspondent

Carla B. Oakley Morgan, Lewis & Bockius LLP

One Market, Spear Street Tower,

San Francisco CA 94105,

UNITED STATES OF AMERICA

SOLVETX

Classification Information

2294450

22 Jul 2022

22 Jul 2032

WORD

26 Jan 2022

Status Date	Action Taken
8^th Nov 2022	International Registration in Australia Protected correspondence sent
7^th Nov 2022	IP Right Registration Published
7^th Nov 2022	Status change to Registered/Protected
30^th Aug 2022	Application Accepted correspondence sent
29^th Aug 2022	IP Right has been Examined
29^th Aug 2022	IP Right Acceptance Published
29^th Aug 2022	Status change to Accepted
26^th Aug 2022	Awaiting examination
26^th Aug 2022	Examination expedited
26^th Aug 2022	Word and image indexing completed